ST
Publicaties op Oncologisch.com
Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic color...
A-BRAVE trial: a phase III gerandomiseerde trial with anti-PD-L1 avelumab in high-risk triple-negative early breast c...
Avelumab bij endometriumcarcinoom naar moleculair profiel: MITO END-3 fase II